Oxybutynin Extended-Release Tablets Recalled for Failed Dissolution Test Results
Zydus Pharmaceuticals is recalling Oxybutynin Extended-Release Tablets (15 mg) after dissolution testing showed out-of-specification results at the 6-month mark. No illnesses have been reported.
- Product
- OXYBUTYNIN — OXYBUTYNIN (OXYBUTYNIN)
- Category
- Drug
- Distribution
- Distributed nationwide